NO20080464L - Terapeutisk kombinasjon omfattende en NMDA-reseptorhemmer og en narkotisk analgesisk substans - Google Patents
Terapeutisk kombinasjon omfattende en NMDA-reseptorhemmer og en narkotisk analgesisk substansInfo
- Publication number
- NO20080464L NO20080464L NO20080464A NO20080464A NO20080464L NO 20080464 L NO20080464 L NO 20080464L NO 20080464 A NO20080464 A NO 20080464A NO 20080464 A NO20080464 A NO 20080464A NO 20080464 L NO20080464 L NO 20080464L
- Authority
- NO
- Norway
- Prior art keywords
- narcotic analgesic
- nmda receptor
- receptor inhibitor
- substance
- analgesic substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05016391 | 2005-07-28 | ||
PCT/EP2006/007049 WO2007017058A1 (en) | 2005-07-28 | 2006-07-18 | Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080464L true NO20080464L (no) | 2008-02-28 |
Family
ID=37114513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080464A NO20080464L (no) | 2005-07-28 | 2008-01-25 | Terapeutisk kombinasjon omfattende en NMDA-reseptorhemmer og en narkotisk analgesisk substans |
Country Status (11)
Country | Link |
---|---|
US (1) | US20080287480A1 (pt) |
EP (1) | EP1909781A1 (pt) |
JP (1) | JP2009502828A (pt) |
AU (1) | AU2006278933A1 (pt) |
BR (1) | BRPI0613281A2 (pt) |
CA (1) | CA2616659A1 (pt) |
MX (1) | MX2008000780A (pt) |
NO (1) | NO20080464L (pt) |
NZ (1) | NZ565416A (pt) |
WO (1) | WO2007017058A1 (pt) |
ZA (1) | ZA200800780B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU20190114A7 (es) * | 2019-12-26 | 2021-08-06 | Centro De Investig Y Desarrollo De Medicamentos Cidem | Combinación para simultáneamente incrementar la eficacia analgésica de la morfina y reducir su dependencia física |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2115792C (en) * | 1993-03-05 | 2005-11-01 | David J. Mayer | Method for the treatment of pain |
DK1321139T3 (da) * | 2001-12-21 | 2007-01-02 | Chiesi Farma Spa | 2-indanylaminoderivater til behandling af kronisk, akut eller inflammatorisk smerte |
-
2006
- 2006-07-18 NZ NZ565416A patent/NZ565416A/en unknown
- 2006-07-18 AU AU2006278933A patent/AU2006278933A1/en not_active Abandoned
- 2006-07-18 BR BRPI0613281-2A patent/BRPI0613281A2/pt not_active IP Right Cessation
- 2006-07-18 CA CA002616659A patent/CA2616659A1/en not_active Abandoned
- 2006-07-18 ZA ZA200800780A patent/ZA200800780B/xx unknown
- 2006-07-18 MX MX2008000780A patent/MX2008000780A/es unknown
- 2006-07-18 JP JP2008523184A patent/JP2009502828A/ja not_active Withdrawn
- 2006-07-18 US US11/995,983 patent/US20080287480A1/en not_active Abandoned
- 2006-07-18 WO PCT/EP2006/007049 patent/WO2007017058A1/en active Application Filing
- 2006-07-18 EP EP06776280A patent/EP1909781A1/en not_active Withdrawn
-
2008
- 2008-01-25 NO NO20080464A patent/NO20080464L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1909781A1 (en) | 2008-04-16 |
ZA200800780B (en) | 2009-05-27 |
NZ565416A (en) | 2011-03-31 |
CA2616659A1 (en) | 2007-02-15 |
US20080287480A1 (en) | 2008-11-20 |
AU2006278933A1 (en) | 2007-02-15 |
JP2009502828A (ja) | 2009-01-29 |
WO2007017058A1 (en) | 2007-02-15 |
MX2008000780A (es) | 2008-02-19 |
BRPI0613281A2 (pt) | 2010-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065936L (no) | Sulfonyletylfosfordiamidater for anvendelse ved behandling av cancer. | |
WO2008039218A3 (en) | Inhibitors of bruton's tyrosine kinase | |
NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
TW200637547A (en) | Compounds and compositions as protein kinase inhibitors | |
MY144044A (en) | Compounds and compositions as protein kinase inhibitors | |
MX2009006007A (es) | Profarmacos y metodos para hacer y usar los mismos. | |
CA2683786C (en) | Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects | |
WO2006066008A3 (en) | Device and methods for identifying and treating aspirin non-responsive patients | |
MX2008000915A (es) | Tratamiento con inhibidores de absorcion de colesterol basados en azetidinona y acidos grasos omega-3 y un producto de combinacion de los mismos. | |
WO2010009342A3 (en) | Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors | |
NO20084256L (no) | DPP IV inhibitorformuleringer | |
WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
NO20055173L (no) | Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel | |
TW200738228A (en) | Neramexane modified release matrix tablet | |
RS20050035A (en) | Therapies for renal failure using interferon-betha | |
MX2009004017A (es) | Usos de los compuestos carboxi-amido triazol y sus sales. | |
MX2007013301A (es) | Agente profilactico/terapeutico para la anormalidades del metabolismo del azucar/lipidos. | |
WO2007044325A3 (en) | Apoe4 domain interaction inhibitors and methods of use thereof | |
EA200970353A1 (ru) | Комбинированное лекарственное средство | |
WO2007047205A3 (en) | Enzyme inhibitors of pai-1 | |
MX2007007206A (es) | Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos. | |
NO20080464L (no) | Terapeutisk kombinasjon omfattende en NMDA-reseptorhemmer og en narkotisk analgesisk substans | |
EA200901062A1 (ru) | Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств | |
UA94434C2 (ru) | Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит | |
TW200633720A (en) | Medicinal composition for diabetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |